Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Completed
CT.gov ID
NCT01299259
Collaborator
(none)
95
1
2
44
2.2

Study Details

Study Description

Brief Summary

The investigators hypothesize that text message reminders to girls diagnosed with pelvic inflammatory disease (PID) in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Text Message Reminders
N/A

Detailed Description

The Centers for Disease Control (CDC) recommends that patients diagnosed with pelvic inflammatory disease (PID) receive follow-up care within 72 hours of diagnosis. However, recent studies show that the majority of teenage girls diagnosed with PID do not receive this follow-up care within 72 hours. We hypothesize that text message reminders to girls diagnosed with PID in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.

Study Design

Study Type:
Interventional
Actual Enrollment :
95 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Treatment
Official Title:
Improving Primary Care Follow-up for Adolescents With PID: A Randomized Controlled Trial Using Text Message Reminders
Study Start Date :
Feb 1, 2011
Actual Primary Completion Date :
Oct 1, 2014
Actual Study Completion Date :
Oct 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Text Message Reminders

Subjects randomized to the the intervention group will receive a total of 4 text messages on days 2 through 5 to remind them to schedule and attend a PCP follow-up appointment

Behavioral: Text Message Reminders
Patients in the intervention group will receive text messages on their cell phones following discharge from the emergency department reminding them to make an appointment with their primary care provider. Text messages will be sent daily for 4 days after discharge from the ED.

No Intervention: Control Group

The control group will not receive any additional reminders to follow-up with PCP.

Outcome Measures

Primary Outcome Measures

  1. PCP follow-up rates will be used to evaluate the efficacy of text message reminders. [PCP follow-up rates will be assessed 7-14 days after discharge from the ED.]

Secondary Outcome Measures

  1. Number of adolescents who accept text message reminders as an measure of feasibility and acceptability. [7-14 days after discharge from the ED]

    The acceptability among adolescents of using text message reminders after ED discharge in adolescents treated in a pediatric ED.

  2. Number of adolescents satisfied with ED care between the control group and intervention group as a measure of patient satisfaction. [7-14 days after ED discharge]

    Patient satisfaction of ED care when receiving text message reminders.

  3. Type of participant characteristics associated with PCP follow-up as a measure of behavior change, compliance and rate of follow-up care [7-14 days after ED discharge]

    Patient characteristics associated with PCP follow-up

  4. Barriers to PCP follow-up from an ED visit to measure use of text message technology and rate of change in follow-up care between groups [7-14 days after ED visit]

    Types of barriers encountered to PCP follow-up from an ED visit for PID care to measure rate of change in follow-up care between groups

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Females aged 15 years and older

  • New diagnosis of PID, as defined by the 2006 CDC minimum criteria for diagnosis of PID, on current ED encounter

  • Determined by attending physician to be appropriate for outpatient treatment

Exclusion Criteria:
  • Patient does not have a cell phone that is capable of receiving text messages

  • Developmental disability

  • Non-English speaking

  • Pregnancy

  • Patient who was enrolled in this study on a prior ED visit

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • Children's Hospital of Philadelphia

Investigators

  • Principal Investigator: Cynthia Mollen, MD, MSCE, Children's Hospital of Philadelphia
  • Study Director: Frances Balamuth, MD, PhD, Children's Hospital of Philadelphia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01299259
Other Study ID Numbers:
  • 10-007744
First Posted:
Feb 18, 2011
Last Update Posted:
Oct 28, 2014
Last Verified:
Oct 1, 2014

Study Results

No Results Posted as of Oct 28, 2014